Contemporary perspectives on elevating eradication rate of helicobacter pylori

Chinese Journal of Gastroenterology

Volumn 15, Issue 2, 2010, Pages 68-70

  Liu, Wenzhong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Drug resistance; Helicobacter pylori; Therapy

Indexed keywords

ANTIBIOTIC AGENT; BISMUTH; PROTON PUMP INHIBITOR;

ANTIBIOTIC THERAPY; ARTICLE; DRUG TREATMENT FAILURE; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; NONHUMAN;

EID: 80054079122     PISSN: 10087125     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1008-7125.2010.02.002     Document Type: Article

References (16)

1. Vakil N. H. pylori treatment: new wine in old bottles? Am J Gastroenterol, 2009, 104 (1): 26-30.
2. Graham DY, Shiotani A. New concepts of resistance in the treatment of Helicobacter pylori infections. Nat Clin Pract Gastroenterol Hepatol, 2008, 5 (6): 321-331. (Pubitemid 351803603)
3. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut, 2007, 56 (6): 772-781. (Pubitemid 46854190)
4. Perna F, Zullo A, Ricci C, et al. Levofloxacin-based triple therapy for Helicobacter pylori re-treatment: role of bacterial resistance. Dig Liver Dis, 2007, 39 (11): 1001-1005. (Pubitemid 350018698)
5. Zullo A, De Francesco V, Hassan C, et al. The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis. Gut, 2007, 56 (10): 1353-1357. (Pubitemid 47517826)
6. Jafri NS, Hornung CA, Howden CW. Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment. Ann Intern Med, 2008, 148 (12): 923-931. (Pubitemid 351860824)
7. Moayyedi P, Malfertheiner P. Editorial: Sequential therapy for eradication of Helicobacter pylori: a new guiding light or a false dawn? Am J Gastroenterol, 2009, 104 (12): 3081-3083.
8. Graham DY, Lu H, Yamaoka Y. Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond. Drugs, 2008, 68 (6): 725-736. (Pubitemid 351550527)
9. Fischbach L, Evans EL. Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori. Aliment Pharmacol Ther, 2007, 26 (3): 343-357. (Pubitemid 47063149)
10. Essa AS, Kramer JR, Graham DY, et al. Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication. Helicobacter, 2009, 14 (2): 109-118.
11. Anagnostopoulos GK, Tsiakos S, Margantinis G, et al. Esomeprazole versus omeprazole for the eradication of Helicobacter pylori infection: results of a randomized controlled study. J Clin Gastroenterol, 2004, 38 (6): 503-506. (Pubitemid 38808423)
12. Villoria A, Garcia P, Calvet X, et al. Meta-analysis: high-dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther, 2008, 28 (7): 868-877.